文献库搜索 | GeneLibs

Qin(C),Xin(H),Wei(Q),Xiao(Q),Yang(G),Ding(... Bioact Mater 2027-01-00

...cancer (LLC-OVA) therapeutic model, vaccines with increasing phenylalanine achieved tumor inhibition rates of 31.62%, 65...

Kawamura(R),Yamada(M),Takamaru(H),Nakajima... DEN Open 2027-04-00

...cancer, as well as superficial non-ampullary duodenal epithelial tumors (SNADETs). In this single-center retrospective s...

Lin(X),Murchú(MÓ),Sheridan(L),Menon(S),Han... Clin Transl Radiat Oncol 2027-01-00

...cancer hallmarks, including sustained proliferative signalling, angiogenesis, metabolic reprogramming, immune evasion, i...

Dinh(T),Lee(J),Islam(S),Nanda(N),Bjelivuk(... Genes Dis 2027-01-00

...cancer immunotherapy. However, therapeutic strategies to induce these structures are currently limited. We evaluated the...

Yu(S),Ke(M),Ma(M),Jiang(T),Li(X),Xie(K) Genes Dis 2027-01-00

...cancer-related death with limited treatment options, and there is an urgent need to develop effective therapeutic strate...

Gulleen(EA),Kabukye(J),Block Ngaybe(MG),Bw... Open Forum Infect Dis 2026-03-00

...Cancer Institute in Kampala, Uganda as a case study to describe how we used PM to identify barriers to antimicrobial del...

Sahi(A),Khattak(AN),Israr(F),Ahmed(S),Khal... Radiol Case Rep 2026-06-00

...cancer, typically metastasizing to regional lymph nodes, peritoneum, and liver. Metastasis to the popliteal fossa is exc...

Jiang(N),Zhang(Y),Li(GF),Qu(XY),Wang(WX),H... Front Med (Lausanne) None

...cancer (NSCLC) patients who may benefit from immunotherapy. This study investigates a novel approach by integrating dual...

Li(H),Luo(J),Ou(S),Zheng(D),Jiang(Q) Front Med (Lausanne) None

Financial toxicity, stemming from high cancer treatment costs, compromises adherence, escalates caregiver burden, and in...

Rosario(M),Sitharthan(D),Delprado(W),Kam(J... Urol Case Rep 2026-05-00

...cancer both clinically and radiologically. Our case highlights the importance of histological confirmation in atypical p...